News

Few teen females prescribed teratogenic meds get contraceptive advice, Rx

View on the News

Contraception advice is key

“Even if a provider does not think it is within his or her scope of care to provide a contraceptive method, asking the questions to assess whether a contraceptive method might be needed from another provider is essential.

“In addition, all providers should be aware of the newer recommendation that all adolescents should be offered the option of a long-acting reversible contraceptive method to prevent pregnancy.

The fact that the Affordable Care Act allows us to provide 18 different contraceptive methods without any cost sharing to the patient should also make adolescent pregnancy prevention easier than ever.”

Erica J. Gibson, M.D., is an expert in adolescent medicine in the department of pediatrics at the University of Vermont Children’s Hospital, Burlington. Her remarks are excerpted from an article published in Pediatrics (2016, Jan. doi:10.1542/peds.2015-3826). She disclosed no conflicts of interest.


 

FROM PEDIATRICS

References

Fewer than one-third of adolescent females prescribed a teratogenic medication were counseled about, prescribed, or referred for contraception, according to a retrospective review of data from a single academic pediatric medical center.

The records from 1,694 female patients aged 14-25 years, who received 4,506 medications of Food and Drug Administration pregnancy risk category D or X – mostly commonly topiramate, methotrexate, diazepam, isotretinoin, or enalapril – showed that contraceptive counseling, prescription, or referral occurred in 29% of visits, according to a paper published online Dec. 16 in Pediatrics.

© khuntapol / ThinkStockPhotos.com

White females were 61% more likely to receive contraceptive provision than were nonwhites, and girls aged 16 years or older were 20% more likely to receive it than were girls aged 14-15 years (Pediatrics 2016, Jan. doi: 10.1542/peds.2015-1454).

Teratogens with a federal surveillance system, such as iPLEDGE or REMS, were associated with twofold increase in the rate of contraceptive provision, but a much lower likelihood of documentation of menstrual and sexual histories.

“This finding was unexpected given that the focus of these systems is to proactively reduce the risk of unplanned pregnancy during drug treatment,” wrote Stephani L. Stancil of Children’s Mercy Hospital, Kansas City, Mo., and coauthors.

“Opportunity exists in these adolescents to increase rates of contraceptive counsel, the prescription of contraception if appropriate, or referral for such care when it becomes necessary to use a medication with known teratogenic potential,” they said.

Children’s Mercy Hospital supported the study. No conflicts of interest were declared.

Recommended Reading

Use of isolation in juvenile detention centers
MDedge Pediatrics
WDC: Transition to adult diabetes care is tough on kids
MDedge Pediatrics
VIDEO: Another worry about energy drinks in kids
MDedge Pediatrics
ASA: Pediatric clinicians over-dispensing opioids, study finds
MDedge Pediatrics
AAP: Screening for vision abnormalities should start at birth
MDedge Pediatrics
Poor pregnancy outcomes seen in teens with type 2 diabetes
MDedge Pediatrics
More time in front of screens linked to more migraines in young adults
MDedge Pediatrics
Most early puberty symptoms are likely benign
MDedge Pediatrics
USPSTF continues to urge syphilis screening in high-risk groups
MDedge Pediatrics
AHA/ACC: Consensus recommendations for young athletes with congenital heart disease
MDedge Pediatrics